Targeting Glioblastoma Tumor Hyaluronan to Enhance Therapeutic Interventions that Regulate Metabolic Cell Properties
Advanced Therapeutics · 2024-10 · 7 (10)
DOI: 10.1002/adtp.202400041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Therapeutics, online erschienen am 11.09.2024. Verfasst von Edward R Neves und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Carl R Woese Institute for Genomic Biology, University of Illinois Urbana-Champaign, 1206 W Greg…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Despite extensive advances in cancer research, glioblastoma (GBM) still remains a very locally invasive and thus challenging tumor to treat, with a poor median survival. Tumor cells remodel their microenvironment and utilize extracellular matrix to promote invasion and therapeutic resistance. It is aimed here to determine how GBM cells exploit hyaluronan (HA) to maintain proliferation using ligand‐receptor dependent and ligand‐receptor independent signaling. Tissue engineering approaches are used to recreate the 3D tumor microenvironment in vitro, then analyze shifts in metabolism, hyaluronan secretion, HA molecular weight distribution, as well as hyaluronan synthetic enzymes (HAS) and hyaluronidases (HYAL) activity in an array of patient‐derived xenograft GBM cells. It is revealed that endogenous HA plays a role in mitochondrial respiration and cell proliferation in a tumor subtype‐dependent manner. A tumor‐specific combination treatment of HYAL and HAS inhibitors is proposed to disrupt the HA stabilizing role in GBM cells. Taken together, these data shed light on the dual metabolic and ligand – dependent signaling roles of hyaluronan in glioblastoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, Carl R Woese Institute for Genomic Biology, University of Illinois Urbana-Champaign, 1206 W Gregory Dr., Urbana IL 61801, USA.
- Materials Research Laboratory, University of Illinois Urbana-Champaign, 104 S Goodwin Ave MC-230, Urbana, IL 61801, USA.
- Tumor Engineering and Phenotyping, Cancer Center at Illinois, University of Illinois Urbana Champaign, Beckman Institute, 405 N. Mathews, Urbana, IL 61801, USA.
- Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois Urbana-Champaign, 2001 S Lincoln Ave. Urbana, IL 61802, USA.
- Department of Radiation Oncology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
- Dept. of Chemical and Biomolecular Engineering, Carl R. Woese Institute for Genomic Biology, Cancer Center at Illinois, University of Illinois Urbana-Champaign, 110 Roger Adams Laboratory, 600 S. Mathews Ave., Urbana, I…
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Neves, E. R., Anand, A., Mueller, J., Remy, R. A., Xu, H., Selting, K. A., Sarkaria, J. N., Harley, B. A., & Pedron-Haba, S. (2024). Targeting Glioblastoma Tumor Hyaluronan to Enhance Therapeutic Interventions that Regulate Metabolic Cell Properties. Advanced Therapeutics, 7(10). https://doi.org/10.1002/adtp.202400041
Vancouver
Neves ER, Anand A, Mueller J, Remy RA, Xu H, Selting KA, et al. Targeting Glioblastoma Tumor Hyaluronan to Enhance Therapeutic Interventions that Regulate Metabolic Cell Properties. Advanced Therapeutics. 2024;7(10). doi:10.1002/adtp.202400041
BibTeX
@article{Neves2024,
author = {Neves, Edward R and Anand, Achal and Mueller, Joseph and Remy, Roddel A and Xu, Hui and Selting, Kim A and Sarkaria, Jann N and Harley, Brendan Ac and Pedron-Haba, Sara},
title = {Targeting Glioblastoma Tumor Hyaluronan to Enhance Therapeutic Interventions that Regulate Metabolic Cell Properties},
journal = {Advanced Therapeutics},
year = {2024},
volume = {7},
number = {10},
doi = {10.1002/adtp.202400041}
}
EUVIMED